Sarepta Therapeutics (SRPT +5.5%) gains after announcing a collaboration agreement with...

|About: Sarepta Therapeutics, Inc. (SRPT)|By:, SA News Editor

Sarepta Therapeutics (SRPT +5.5%) gains after announcing a collaboration agreement with University College and the Dubowitz Neuromuscular Centre in London to further develop exon-skipping drug therapies for Duchenne muscular dystrophy.